Skip to main content

Emerging Roles for Riboflavin in Functional Rescue of Mitochondrial β-Oxidation Flavoenzymes

Buy Article:

$55.00 plus tax (Refund Policy)

Riboflavin, commonly known as vitamin B2, is the precursor of flavin cofactors. It is present in our typical diet, and inside the cells it is metabolized to FMN and FAD. As a result of their rather unique and flexible chemical properties these flavins are among the most important redox cofactors present in a large series of different enzymes. A problem in riboflavin metabolism or a low intake of this vitamin will have consequences on the level of FAD and FMN in the cell, resulting in disorders associated with riboflavin deficiency. In a few number of cases, riboflavin deficiency is associated with impaired oxidative folding, cell damage and impaired heme biosynthesis. More relevant are several studies referring reduced activity of enzymes such as dehydrogenases involved in oxidative reactions, respiratory complexes and enzymes from the fatty acid β-oxidation pathway. The role of this vitamin in mitochondrial metabolism, and in particular in fatty acid oxidation, will be discussed in this review. The basic aspects concerning riboflavin and flavin metabolism and deficiency will be addressed, as well as an overview of the role of the different flavoenzymes and flavin chemistry in fatty acid β-oxidation, merging clinical, cellular and biochemical perspectives. A number of recent studies shedding new light on the cellular processes and biological effects of riboflavin supplementation in metabolic disease will also be overviewed. Overall, a deeper understanding of these emerging roles of riboflavin intake is essential to design better therapies.





No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Disease; Flavin; Mitochondrial metabolism; Protein folding; Riboflavin; Riboflavin-responsive; acyl-CoA dehydrogenase defi-ciency (RR-MADD); acyl-carnitine translocase (CAT); aminomonophosphate (AMP); biophysics; carbonylation; carnitine palmitoyl transferase I (CPT I); cell damage; conformational destabilisation; dehydrogenases; electron transferring flavoprotein (ETF); ethylmalonic-adipic aciduria; fatty acid -oxidation pathway; fatty acid oxidation (FAO); flavin adenine dinucleotide (FAD); flavin mononucleotide (FMN); flavoenzymes; glutaryl-CoA dehydrogenase; heme biosynthesis; isoalloxazine ring system; isovaleryl-CoA dehydrogenase (IVD); lymphoid cells; mass spec-trometry; oxidative folding; respiratory complexes; riboflavin transporter 2 (RFT2); semiquinone form; semiquinone radical; short chain acyl-CoA dehydrogenase (SCAD); vitamin B2

Document Type: Research Article

Publication date: 2010-11-01

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more